In 2008, Madeline “Kara” Neumann, age 11, died of diabetic ketoacidosis in Wisconsin. Her parents treated her symptoms with ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, joining multiple biotech companies that have lost government funding for their ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Health Secretary Robert F. Kennedy Jr. has refused to acknowledge how his anti-vaccine rhetoric endangers public health ...

Public health workers and gun safety advocates gathered at a rally Tuesday night to commemorate last week’s deadly shooting near Emory University and the Centers for Disease Control and Prevention, ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...